Musculoskeletal Flashcards
Tubocurarine
Induces muscle paralysis
A drug that blocks the acetylcholine at its receptor, preventing interaction and subsequent deplolarization.
Succinylcholine
A Phase I block depolarizing neuromuscular blocking drug.
Induces a depolarizing blockade by over-stimulation of Acetylcholine receptors.
Chemically, it is two acetylcholine molecules linked end-to-end
Short half life due to rapid hydrolysis by butyrylcholinesterase and pseudocholinesterase in the liver and plasma, respectively.
“Dibucaine number” is used to test for genetic varients in esterases leading to prolonged action
Augmented by esterase inhibitors.
Can cause cardiac arrhythmias, cardiac arrest in burn patients, nerve damage, closed head injury, and other trauma; also may cause increased intraocular pressure and myalgia.
Neuromuscular Blocking Drugs
All neuromuscular blocking drugs are highly polar compounds and inactive orally; they must be administered parenterally.
They all have presence of one or two quaternary nitrogens, limiting entry to CNS and cell membranes.
Characterized by a rapid initial distribution phase followed by a slow elimination phase.
Drugs eliminated by the kidneys have a longer half-life than those eliminated by the liver.
Vecuronium
An intermediate-acting steroid nondepolarizing muscle relaxant that depends on biliary excretion or hepatic metabolism for elimination.
More commonly used than longer acting pancuronium
Minimal cariac effects
Atracurium
An intermediate-acting isoquinoline nondepolarizing muscle relaxant.
Metabolized by the liver and naturally breaks down through Hofmann elimination.
Laudanosine is a breakdown product that in sufficient quantities can cross the BBB and induce seizures.
Cisatracurium is a more clinically used isomer
Cardiac effects (hypotension)
Mivacurium
Isoquinoline compound that has the shortest duration of action of all nondepolarizing muscle relaxants.
Onset is slower than succinylscholine.
Larger doses can lead to histamine release.
No longer in widespread clinical use
Pancuronium
80% eliminated by Kidney (thus long lasting)
Causes a moderate increase in heart rate and a smaller increase in cardiac output.
Reversal of Nondepolarizing Neuromuscular Blockade
Neostigmine and Pyridostigmine antagonize acetylcholinesterase, allowing more acetylcholine to be present at the synapse.
They also increase release from nerve terminal (unlike edrophonium)
Malignant Hyperthermia
Treated with dantrolene. It is a rare heritable disorder that can be triggered by a variety of stimuli including succinylcholine.
They have a hereditary alteration in Ca2+ channels leading to prolonged release. This leads to increased acidosis and body temperature
Diazepam
Acts at GABA-a synapses
Causes sedation
Dantrolene
interferes with the release of activator calcium through the ryanodine receptor channel by binding and blocking the channel’s opening.
Cardiac muscle and smooth muscle are not affected due to different isoforms
It is used as a spasmolytic drug, weakens skeletal muscle contraction
Can be used to treat malignant hyperplasia and Neuroleptic malignant syndrome.
Cyclobenzaprine
Work primarily at the brainstem
Structurally related to tricyclic antidepressants and produces antimuscarinic side effects.
Ineffective in treating muscle spasm due to cerebral palsy or spinal cord injury.
May cause serious sedation, confusion, visual hallucinations
Glucocorticoid
Prevent production of certain mediators of inflammatory reactions. Centered around phospholipase A2
This releases arachidonic acid, which is used to make prostaglandins, thromboxanes, leukotrienes, epoxides, and isoprostanes.
Glucocorticoids inhibit PLA2 on a nuclear scale (genetic)
COX I and II
COX I is constituitively expressed, COX II is expressed in platelets and inflammatory cell types when stimulated by cytokines and bradykinin.
COX I is thought to be expressed at a basal rate for everyday needs of the cell.
COX II is key player in inflammatory response.
In general, NSAIDs are nonselective, but there are some selective COX II inhibitors
Leukotrienes and Epoxides
Especially relevant in response to asthma
They are either 15, 12, or 5
Epoxides are made through Cytochrome p450s.
NSAIDs don’t affect lipoxygenases, epoxides, or isoprostane synthesis.
Glucocorticoids affect all of the above by hitting PLA2
Arachidonic Acid Pathway
Arachidonic acid is converted to PGH2 which is taken immediately to other prostaglandins or thromboxanes.
COX is the main enzyme to get to PGH2
The pathways are very cell specific, meaning one type of cell normally only has one end-product.
PGI2 is in vascular endothelium
Thromboxane A2 is in platelets
Biological Effects of Eicosanoids
PGE2, PGI2, and PGD2 are dilators, while PGF2alpha and TxA2 are constrictors
TxA2 induces platelet aggregation and constricts bronchial smooth muscle
PGI2 inhibits platelet aggregation and dilates bronchial smooth muscle
LTC4 and LTD4 dilate and create leaky capillaries to get cells to inflammator site
PGE2, PGI2, and LTB4 (chemotactic) are all algesics
PGE2 is synthesized by the OVLT to induce fever (local production in brain.
PGE2 and PGF2alpha contract uterus (don’t give NSAIDs to patients in labor)
PGE2, PGI2 decrease GI acid secretion, incerase mucus and bicarb secretion, and increase GI and renal blood flow, decreases chloride resporption in loop of Henle and ADH induced water reabsorption.
NSAID uses and side effects
general anti-inflammatory action
musculoskeletal disease
mechanical injury
rheumatoid arthritis
osteoarthritis
ankylosing spondylitis
analgesia: pain associated with inflammation and moderate pain of headache, myalgia dysmenorrhea
anti-pyretic
Side effects: GI discomfort and ulceration, decreased renal function in patients with compromised renal function, (Less common: dizziness, anxiety, drowsiness, skin rash)
Aspirin
Unique in that it is an irreversible inhibitor by acetylating a serine residue of COX-1 and COX-2
Has side effects of tinnitus and uncoupling of ox. phos.
Aspirin is used to target platelets, since they have no nucleus and cannot regenerate COX once it is covalently inactivated.
Aspirin can antagonize probenecid at low doses, uricosuric at high doses (Aspirin/salicylates are bad for gout)
Has some adjunct therapy in colon cancer
Other Salicylates
Mesalamine, sulfasalazine, and osalazine are all used for inflammatory bowel syndrome.
Sulfasalazine is mesalamine with an antibiotic sulfapyridine attached to it. It is used to treat rheumatoid arthritis as well.
Osalazine is a drug that consists of two mesalamine molecules linked together.
The linkages travel as an inert component until it gets to the bowel, where bacteria are able to break down the unique azole bond and activate the drugs
Diflunisal has poor CNS penetration and no anti-pyretic effect, but has potent anti-inflammatory action
Acetaminophen
Not a good anti-inflammatory drug
It is a good analgesic and anti-pyretic
Outside of the CNS, it doesn’t remain active.
Can cause liver toxicity that is fatal if untreated. Acetaminophen is either conjugated and excreted in the kidney, or metabolized by a p450 (liver) that leads to a reactive metabolite. When glutathione is around, the metabolite is reduced and there are no problems. With less glutathione, the metabolite reacts with protein sulfhydryl groups (overdose).
Treat overdose with N-acetylcysteine
Happens at about 4X recommended dose.
Infants have less of a conjugation reaction, more frequent overdoses.
Indomethacin
very potent COX inhibitor
high degree of side effects with chronic use (over half of patients who take long term have GI effects)
Ob/Gyn use: suppress uterine contractions
closure of patent ductus arteriosus (prostaglandins normally keep it open)
Can be used to treat acute gout
Sulindac
COX inhibitor
Unique: It’s a pro-drug, metabolically activated by the liver.
This has potential less GI side effects, because the form that hits the stomach is inactive.
Etodolac
Very potent anti-inflammatory with less GI side effects.
It is a slightly selective COX-2 inhibitor, which is responsible for sparing GI.
Mefenamic acid and meclofenamate
analgesic, treatment of arthritis
- not recommended as initial therapy
- may antagonize prostaglandin effects
Higher than normal toxicity, usually used when someone responds specifically to them.
They may also have some prostaglandin receptor antagnosim to them
Tolmetin
Studied a lot in pediatric populations, so it is used in pediatric populations
It is well-tolerated, and is used sometimes for juvenile arthritis
Ketorolac
Similar to acetomenaphen, but without the liver toxicity.
Doesn’t due anti-inflammatory
Used to treat post-op pain as alternative to opiates
Can be given IM
Diclofenac
very potent COX inhibitor
may reduce release and/or uptake of arachidonic acid
can be formulated with misoprostol to reduce GI toxicity
Misoprostol is a PGE analog, which is thought to be a GI protector. It hasn’t worked so well because this causes diarrhea.
Ibuprofen
Increasing popularity due to less GI side effects
Naproxen: more potency, same side effects
Ketoprofen: stabilized lysosomal membranes and antagonize bradykinin actions
Oxaprozin: long half life
Fenoprofen, fluribiprofen: similar to others
Piroxicam
in addition to being a COX inhibitor,
inhibits neutrophil activation in the presence of PGs
may inhibit proteoglycanase and collagenase in cartilage
long half-life - - 50 hrs
Must be careful with dose, as it is eliminated slowly
Meloxicam/Nabumetone
A semi-selective COX-2 inhibitor, was replaced by celecoxib.
Nambumetone is the same, but is a pro-drug
Most COX-2 inhibitors have been pulled from the market. The COX-2 inhibitors lead to big problems
Celecoxib
A COX-2 selective inhibitor that has no GI effects
It hits the kidney hard and can cause hypertension.
The COX-2 inhibitors don’t have an anti-platelet effect. This lead to increased MI’s, athersclerotic events, et c.
Other members of class had more problems than Celecoxib
Still a good drug for someone who needs chronic, long term NSAID use but who had GI trouble and who is not at risk for cardio or kidney disease
Glucocorticoids
-Means they are derived from cholesterol and are very lipophyllic. They go through membranes and find cytoplasmic receptors.
They effect gene transcription in a positive or negative manner depending on the cell/gene
They are also immunosuppressive (NSAIDs aren’t). Decrease IL-2,-4,-6, cell adhesion molecules (this can lead to minor increased WBC)
They hit two steps of Arachidonic acid pathway, COX-2 and PLA2
Most tissues are responsive to glucocorticoids, meaning their effects are wide-felt
Glucocorticoid Comparison
Cortisol has a short duration of action and a small anti-inflammatory effect (sodium retaining)
Prednisone has an intermediate duration and 4X the anti-inflammatory effect (sodium retaining) (prednisone requires liver activation)
Triamcinolone has an intermediate duration, has 5X the effect, and no sodium retaining potency
Betamethasone and Dexamthasone have a long duration, 25X the anti-inflammaroty effect, and no sodium retaining potency
Fludrocortisone is 125X more potent for sodium retention, used for patients lacking aldosterone (need sodium retention)
Colchicine
An acute gout drug
- Binds to tubulin and prevents polymerization into microtubules
- Interferes with mitotic spindle function
- Inhibits migration and phagocytic actions of granulocytes
- Inhibits neutrophil secretion of chemotactic factorscommon side effects:
nausea, vomiting, diarrhea, abdominal pain
affects rapidly proliferating epithelial cells in GI tract
Used when NSAIDs or glucocorticoids haven’t worked
NSAIDs for Gout
NSAIDs are used for gout. The heavy hitters are used because they won’t be used long term
Ibuprofen, naproxen, indomethacin, sulindac
DON’T USE ASPIRIN
Allopurinol
Chronic gout drug
parent drug and metabolite alloxanthine inhibit
xanthine oxidase, decreases uric acid synthesis
drug interaction: inhibits **metabolism** of azathioprine, 6-mercaptopurine (chemotherapeutics, need to back off the dose)
Gout often affects patients undergoing chemo for cancer
can be used with impaired renal function
Febuxostat
Chronic gout drug
Nonpurine xanthine oxidase inhibitor
Liver function abnormalities, diarrhea, nausea
Rasburicase
Chronic gout drug
Recombinant urate oxidase
Converts uric acid into soluble and inactive metabolite
Probenecid
Chronic gout drug
Uricosuric agent: means it blocks reabsorption of uric acid in kidney in tubules
Developed in WWII to inhibit secretion of penicillin (still blocks this, leading to increased penicillin doses)
Multiple drug interactions by blocking renal secretion of other drugs
Rheumatoid Arthritis
Previously, you would start by treating with NSAIDs, which relieve pain but don’t modify disease
Now, you try and modify the disease
Methotrexate
Used to treat rheumatoid arthritis
MOA is not extremely well known.
Adverse affects: nausea and mucosal ulcers, hepatotoxicity. Can use leucovorin rescue, but lowers effect. Hepatotoxicity is such a prominent side-effect, one needs to check liver biopsy samples every 5 years.
Cyclophosphamide
DMARD for RA
alkylating agents/cross link DNA
toxic effects of bone marrow suppression, infertility,
increased risk of infections and neoplasia
Sulfasalazine
Azo linkage of sulfapyridine and 5-aminosalicylic acid
Acts by scavenging free radicals and as COX inhibitor
and dihydrofolate reductase inhibitor
Abatacept
DMARD for RA
inhibits T-cell activation by binding to
CD80 and 86 (on APCs) and preventing
interaction with CD28 (on T cells)
given by IV infusion
increased risk of infection especially in combination
with anti-TNF agents
Rituximab
DMARD for RA
monoclonal antibody that targets CD20 (on B-cells)
depletion of B lymphocytes decreases antigen presentation to T lymphocytes
given by IV infusion, often combined with methotrexate
main use in treatment of rheumatoid arthritis refractory
to anti-TNF agents
rash in 30% patients with first treatment
Tocilizumab
IL-6 receptor antagonist
Used in RA when it hasn’t responded to other drugs
Anakinra
IL-1 receptor antagonist
RA drug
Used when response is lacking to other DMARD therapies
Anti TNF►alpha drugs
Anti- TNF-alpha drugs
Etanercept: recombinant fusion protein consisting of
two soluble TNF receptor regions linked to
Fc portion of human IgG
Infliximab: chimeric monoclonal antibody with
variable murine region linked to constant human region
specific against human TNF
Adalimumab: Recombinant human anti-TNF monoclonal antibody
Golimumab: Recombinant human anti-TNF monoclonal antibody
Certolizumab: Fab fragment conjugated to PEG, binds TNF
agents must given by injection
antibodies develop against these drugs
but don’t appear to alter efficacy
increase risk of macrophage dependent infections
screen for latent or active tuberculosis
Mycophenolate Mofetil
DMARD for RA
Inhibits inosine monophosphate dehydrogenase
Decreases de novo purine biosynthesis
T and B cell sensitive due to lack of salvage pathway
interferes with leukocyte adhesion by inhibition of E- and P-selectin expression
Azathioprine
DMARD for RA
converted to 6-mercaptopurine, inhibits de novo purine synthesis
primary targets T and B cells
toxicity - - any rapidly growing cell population